These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Clinical pharmacology of the reversal of neuromuscular block. Gyermek L. Int J Clin Pharmacol Biopharm; 1977 Aug; 15(8):456-62. PubMed ID: 892958 [No Abstract] [Full Text] [Related]
9. Metabolites of neostigmine and pyridostigmine do not contribute to antagonism of neuromuscular blockade in the dog. Hennis PJ, Cronnelly R, Sharma M, Fisher DM, Miller RD. Anesthesiology; 1984 Nov; 61(5):534-9. PubMed ID: 6149707 [Abstract] [Full Text] [Related]
10. Profound atracurium induced neuromuscular blockade. A comparison of evoked reversal with edrophonium or neostigmine. Casson WR, Jones RM. Anaesthesia; 1986 Apr; 41(4):382-5. PubMed ID: 3754698 [Abstract] [Full Text] [Related]
18. Comparison of anticholinesterases and their effects on acetylcholine-activated ion channels. Wachtel RE. Anesthesiology; 1990 Mar; 72(3):496-503. PubMed ID: 2310031 [Abstract] [Full Text] [Related]
19. Absence of "recurarization" in patients with demonstrated prolonged neuromuscular block. Lee C, Mok MS, Barnes A, Katz RL. Br J Anaesth; 1977 May; 49(5):485-9. PubMed ID: 861117 [Abstract] [Full Text] [Related]
20. Failure to reverse prolonged vecuronium-induced neuromuscular blockade with edrophonium in an anesthetized dog. Martin-Flores M, Boesch J, Campoy L, Gleed RD. J Am Anim Hosp Assoc; 2011 May; 47(4):294-8. PubMed ID: 21673340 [Abstract] [Full Text] [Related] Page: [Next] [New Search]